ARCHIVES

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

This article is from The Cancer Letter archive.

Vol. 30 No. 3 | March 30, 2007

Download PDF Visit The Full Archive

Related Articles

Environmental Carcinogenesis Gets 17% Of NCI Budget

February 20, 1976

NCI Advisors: Resume Prevention Trial, Add Edometrial Sampling

May 13, 1994

FDA, HCFA Form Council On Biomedical Imaging.

November 10, 2000

RF Numbers To Drop Noticeably Soon, Upton Tells AACR

April 14, 1978

DeVita Era At NCI One Of New Programs, Remarkable Stability

August 19, 1988

Prevention Program Being Developed For Primary Providers

January 29, 1988